Atlas Trials

Caffeine, CYPA12 and Resistance Exercise

Clinical trial NCT06610110 · COMPLETED

Trial details

NCT number
NCT06610110
Sponsor
Alberto Pérez-López
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
CYP1A2 PolymorphismCaffeine and Resistance Exercise
Start date
2024-04-01
Primary completion
2025-07-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.